[Ivacaftor (cystic fibrosis) - Addendum to Commissions G20-18, G20-20, A20-77, A20-83]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003805
German
Original Title:
Ivacaftor (Kombination mit Ivacaftor/Tezacaftor/Elexacaftor; zystische Fibrose, ab 12 Jahre, F508del-Mutation) -Addendum zu den Aufträgen G20-18, G20-20, A20-77, A20-83
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/g21-03.html
Year Published:
2021
URL for published report:
https://www.iqwig.de/download/g21-03_ivacaftor_addendum-zu-den-auftraegen-g20-18-g20-20-a20-77-a20-83_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Cystic Fibrosis
- Child
- Adolescent
- Adult
- Drug Therapy, Combination
- Chloride Channel Agonists
- Quinolones
Keywords
- Ivacaftor
- Tezacaftor
- Elexacaftor
- Cystic Fibrosis
- Child
- Adolescent
- Adult
- Health Care Costs
- Epidemiology
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.